Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Aleafia Health Inc ALEAF

Aleafia Health Inc. is a federally licensed Canadian cannabis company offering cannabis products in Canadian adult-use and medical markets and in select international markets. The Company is engaged in the production, sale, and distribution of cannabis. It operates a virtual medical cannabis clinic staffed by physicians and nurse practitioners which provide health and wellness services across... see more

GREY:ALEAF - Post Discussion

View:
Post by Oceanis on Nov 11, 2021 7:51am

Whew.

Aleafia Health Reports Q3 2021 Financial Results with 123% Increase in Cannabis Net Revenue

GlobeNewswireNov 11, 2021 7:00 AM EST
  • $9.6 million net revenue with an improved sales mix focused on the high-growth adult-use and recurring medical cannabis sales channels
  • 2,044% y/y increase in adult-use cannabis net revenue
  • 31% y/y increase in medical cannabis net revenue
  • Top 10 in national market share in pre-rolls achieved subsequent to the reporting period 1
  • Top 10 in national adult-use market share in edibles and oils categories 1
  • Outdoor harvest produced average yield on THC-dominant dried flower of 22%
  • SG&A expenses declined 24% over the previous quarter
  • Strengthened product portfolio with a total of 35 and 46 SKUs listed in Ontario and Alberta respectively by January 2022

TORONTO, Nov. 11, 2021 (GLOBE NEWSWIRE)

Comment by rad10 on Nov 11, 2021 7:54am
LOL -  read the balance sheet....................  raise is coming, maybe a recapitalisation.  Noteholders own this outfit.
Comment by KeyserShoze on Nov 11, 2021 8:17am
This post has been removed in accordance with Community Policy
Comment by rad10 on Nov 11, 2021 8:37am
Keyser - you'll have to explain Sedar to the fluff boys.  They are unfamiliar with this level of research. I'll skip the conference call - we can put a fork in this one.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities